ReviewDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver2022
Covid-19 and alcohol associated liver disease.
Review in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
37 citing papers in PubMed, 49 citations in OpenAlex.
- Gastroenterologist's Guide to Assess for Alcohol Use.Digestive diseases and sciences · 2026Review
- Patterns of substance-induced psychosis during the COVID-19 pandemic: a national registry study of specialist healthcare contacts.Social psychiatry and psychiatric epidemiology · 2026Article
- Sex and age differences in alcohol-attributable mortality in Chile between 2008 and 2022.Public health in practice (Oxford, England) · 2026Article
- Changes in Disease Severity and Outcomes Among Electively Admitted Cirrhosis Patients During the COVID-19 Era.Healthcare (Basel, Switzerland) · 2026Article
- The global epidemiology of alcohol-associated liver disease.Hepatology communications · 2026Review
- Gut microbiome and bile acid metabolism in liver disease: Mechanisms, clinical implications, and therapeutic opportunities.Pharmacological reviews · 2026Review
- Medications for Alcohol Use Disorder Among Patients With Severe Alcohol-Related Liver Disease.JAMA network open · 2026Article
- Reducing alcohol-associated liver disease burden in the general population.The lancet. Gastroenterology & hepatology · 2025Review
- "The alcohol-harm paradox": Understanding socioeconomic inequalities in liver disease.JHEP reports : innovation in hepatology · 2025Review
- Alcohol-associated liver disease is associated with less adverse outcomes compared to nonalcohol-associated liver disease in patients with COVID-19.Alcohol, clinical & experimental research · 2025Observational
- Where Do Patients With Cirrhosis Die? A CDC WONDER Analysis From 1999 to 2020.JGH open : an open access journal of gastroenterology and hepatology · 2025Article
- Differential candidate characteristics associated with increasing ALD and MASH among liver transplant listings in the US.Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver · 2025Article
- Article
- Excess mortality in people hospitalised for alcohol use disorders before and during the pandemic - A registry-based retrospective cohort study.Drug and alcohol review · 2025Article
- Women and People From Deprived Areas Are Less Likely to be Assessed for Liver Transplantation for Alcohol-related Liver Disease: Results From a National Study of Transplant Assessments.Transplantation direct · 2025Article
- Mortality and hospitalizations fully attributable to alcohol use before versus during the COVID-19 pandemic in Canada.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2025Article
- Factors Associated With Motivation to Reduce Alcohol Use Among Patients With Chronic Liver Disease.Alimentary pharmacology & therapeutics · 2025Article
- Liver transplantation for alcohol-associated liver disease: The changing landscape.Hepatology forum · 2025Review
- The effect of SARS-CoV-2 infection on the liver function tests: a systematic review and meta-analysis of observational studies.Przeglad gastroenterologiczny · 2025Review
- Association of binge alcohol use with functional outcomes among individuals with COVID-19 infection.Alcohol and alcoholism (Oxford, Oxfordshire) · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 3 institutions in 1 country.
Funding
Abstract
The COVID-19 pandemic is having substantial impacts on the health status of individuals with alcohol use disorder (AUD) and alcohol-associated liver disease (ALD). AUD and ALD have both been impacted throughout the pandemic, with increases in alcohol use during the early stages of the pandemic, reduced access to treatment during the mid-pandemic, and challenges in managing the downstream effects in the post-COVID era. This review will focus on how the COVID-19 pandemic has impacted AUD and ALD epidemiology and access to treatment, and will discuss to address this rising AUD and ALD disease burden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.